Nebido by Bayer is a pharmaceutical-grade testosterone undecanoate injectable formulation, characterized by its long-acting 1000 mg concentration and extended-release pharmacokinetic profile. Testosterone undecanoate is one of the longest-estered testosterone compounds available in clinical practice, with an established role in androgen replacement therapy for male hypogonadism.
✔ Key Research Insights
- Studied for its role in supporting muscle protein synthesis and lean mass parameters in research subjects with androgen deficiency
- Investigated for its effects on endurance, strength indices, and physical performance in clinical observations
- Researched for its influence on post-exertion recovery markers and fatigue reduction in documented subject populations
- Examined for its effects on libido, mood regulation, and energy homeostasis in hypogonadal male subjects
- Documented for its extended-release pharmacokinetic profile, with a single administration associated with stable serum testosterone levels over 10–14 weeks
- Manufactured by Bayer to pharmaceutical-grade standards, with consistent potency and safety documentation
📦 Product Specifications
- Manufacturer: Bayer
- Form: Injectable (Intramuscular)
- Molecule: Testosterone Undecanoate
- Concentration: 1000 mg
- Volume: 4 ml vial
- Dosage considerations may vary. Consulting a qualified professional is recommended.
⚙ How It Works
Testosterone undecanoate is a long-estered testosterone compound administered via intramuscular injection. Following administration in research subjects, the undecanoate ester undergoes gradual enzymatic hydrolysis, releasing free testosterone into systemic circulation over an extended period. This slow-release mechanism is associated with stable serum androgen concentrations, minimizing the hormonal fluctuations observed with shorter-acting testosterone esters. The resulting sustained androgen exposure has been documented in clinical literature for its effects on protein synthesis, recovery parameters, and overall hormonal homeostasis in male subjects undergoing testosterone replacement protocols.
⭐ Product Overview
- Manufactured by Bayer, a globally recognized pharmaceutical company with an established presence in clinical endocrinology
- Trusted formulation referenced in hospital and TRT clinic settings worldwide
- Extended-release profile associated with reduced administration frequency compared to shorter-acting testosterone esters
- Consistent potency and pharmaceutical-grade quality assurance across documented production batches
- Widely referenced in international androgen replacement therapy guidelines under the testosterone undecanoate and Nebido designations
Nebido 1000mg Testosterone Undecanoate Injection | Bayer
Yes, Nebido is a medically approved anabolic steroid containing testosterone undecanoate, the natural male hormone. It’s primarily used in testosterone replacement therapy (TRT) under medical supervision to treat low testosterone, rather than as a recreational anabolic steroid.
Most users begin noticing improvements within 3–6 weeks after the first Nebido injection. Full effects on energy, mood, muscle mass, and libido typically appear after 2–3 months, once testosterone levels stabilize.





















